Stay updated on Safety of Tarlatamab in Adults With SCLC Clinical Trial

Sign up to get notified when there's something new on the Safety of Tarlatamab in Adults With SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Tarlatamab in Adults With SCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page footer revision label changed from v3.5.3 to v3.5.4, indicating a minor version update to the page.
    Difference
    0.0%
    Check dated 2026-05-15T02:10:39.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The history now includes a new revision entry labeled v3.5.3 and removes the previous v3.5.2, indicating the record has been updated to a newer version.
    Difference
    0.0%
    Check dated 2026-04-30T15:47:36.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    Added revision entry v3.5.2 and removed revision v3.5.0 from the record history.
    Difference
    0.0%
    Check dated 2026-04-16T10:58:37.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Added revision: v3.5.0 to the history and removed revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-18T18:17:59.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    - Revision history updated: v3.4.3 added and v3.4.2 removed.
    Difference
    0.0%
    Check dated 2026-03-11T16:41:18.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed prior non-critical notices including a government funding/operating status message (Revision: v3.4.1).
    Difference
    0.3%
    Check dated 2026-02-11T03:14:13.000Z thumbnail image

Stay in the know with updates to Safety of Tarlatamab in Adults With SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Tarlatamab in Adults With SCLC Clinical Trial page.